OR WAIT null SECS
February 06, 2023
Delivering value with enterprise program management.
January 11, 2023
What the c-suite should consider in today’s marketplace.
As they are forced to do more with less, pharma commercial leaders should rethink their incentive programs to ensure their sales teams remain strong drivers of growth.
Pharma companies are teaming with academic institutions earlier in the R&D process.
Interpreting what the Inflation Reduction Act could mean for biopharma.
How technology will play a big role in advancing pharma approaches in patient support.
As new channels enter healthcare conversation mix, engagement strategies are changing.
An evolving job market has forced life sciences companies to respond.
The steps companies can take now to better protect themselves and their data.
January 04, 2023
Baker spoke on topics ranging from pricing, access, the war for talent, and other key areas that are impacting pharma companies.